ES2158496T3 - ISOLABLE MIXTURES FROM LAMARCK JAMBOLAN EUGEN GRAINS, ITS PREPARATION AND THE USE OF THESE BLENDS AND SOME OF ITS CONSTITUENTS AS MEDICATIONS. - Google Patents

ISOLABLE MIXTURES FROM LAMARCK JAMBOLAN EUGEN GRAINS, ITS PREPARATION AND THE USE OF THESE BLENDS AND SOME OF ITS CONSTITUENTS AS MEDICATIONS.

Info

Publication number
ES2158496T3
ES2158496T3 ES97904475T ES97904475T ES2158496T3 ES 2158496 T3 ES2158496 T3 ES 2158496T3 ES 97904475 T ES97904475 T ES 97904475T ES 97904475 T ES97904475 T ES 97904475T ES 2158496 T3 ES2158496 T3 ES 2158496T3
Authority
ES
Spain
Prior art keywords
mixtures
lamarck
jambolan
eugen
isolable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97904475T
Other languages
Spanish (es)
Inventor
Ratsimamanga Albert Rakoto
Ratsimamanga Suzanne Rakoto
Philippe Rasoanaivo
Jean Leboul
Jean Provost
Daniel Reisdorf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INST MALGACHE DE RECH S APPLIQ
Aventis Pharma SA
Original Assignee
INST MALGACHE DE RECH S APPLIQ
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST MALGACHE DE RECH S APPLIQ, Aventis Pharma SA filed Critical INST MALGACHE DE RECH S APPLIQ
Application granted granted Critical
Publication of ES2158496T3 publication Critical patent/ES2158496T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Tea And Coffee (AREA)
  • Steroid Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A MEZCLAS AISLABLES A PARTIR DE SEMILLAS DE EUGENIA JAMBOLANA LAMARCK, SU PREPARACION, LOS MEDICAMENTOS QUE CONTIENEN DICHAS MEZCLAS O COMPONENTES DE LAS MISMAS Y LA UTILIZACION DE DICHAS MEZCLAS Y SUS COMPONENTES PARA LA PREPARACION DE UN MEDICAMENTO.THE INVENTION REFERS TO ISOLABLE MIXTURES FROM LAMARCK JAMBOLAN EUGEN SEEDS, THEIR PREPARATION, THE MEDICINES CONTAINING THESE MIXTURES OR COMPONENTS OF THE SAME AND THE USE OF THESE MIXTURES AND THE COMPONENTS OF THE COMPONENTS.

ES97904475T 1996-02-06 1997-02-03 ISOLABLE MIXTURES FROM LAMARCK JAMBOLAN EUGEN GRAINS, ITS PREPARATION AND THE USE OF THESE BLENDS AND SOME OF ITS CONSTITUENTS AS MEDICATIONS. Expired - Lifetime ES2158496T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9601389A FR2744365B1 (en) 1996-02-06 1996-02-06 INSULABLE MIXTURES FROM EUGENIA JAMBOLANA LAMARCK SEEDS, THEIR PREPARATION AND THE USE OF SUCH MIXTURES AND SOME OF THEIR CONSTITUENTS AS MEDICAMENTS

Publications (1)

Publication Number Publication Date
ES2158496T3 true ES2158496T3 (en) 2001-09-01

Family

ID=9488865

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97904475T Expired - Lifetime ES2158496T3 (en) 1996-02-06 1997-02-03 ISOLABLE MIXTURES FROM LAMARCK JAMBOLAN EUGEN GRAINS, ITS PREPARATION AND THE USE OF THESE BLENDS AND SOME OF ITS CONSTITUENTS AS MEDICATIONS.

Country Status (34)

Country Link
US (4) US5972342A (en)
EP (1) EP0879058B1 (en)
JP (2) JP4570694B2 (en)
KR (1) KR100494625B1 (en)
CN (2) CN1080566C (en)
AR (1) AR005726A1 (en)
AT (1) ATE201826T1 (en)
AU (1) AU726628B2 (en)
BG (1) BG63288B1 (en)
BR (1) BR9707613A (en)
CA (1) CA2245701C (en)
CZ (1) CZ292800B6 (en)
DE (1) DE69705108T2 (en)
DK (1) DK0879058T3 (en)
DZ (1) DZ2174A1 (en)
EA (1) EA001463B1 (en)
ES (1) ES2158496T3 (en)
FR (1) FR2744365B1 (en)
GR (1) GR3036007T3 (en)
HU (1) HU227958B1 (en)
IL (1) IL125598A (en)
MA (1) MA24077A1 (en)
NO (1) NO318694B1 (en)
NZ (1) NZ331241A (en)
PL (1) PL186798B1 (en)
PT (1) PT879058E (en)
RS (1) RS49527B (en)
SK (1) SK282672B6 (en)
TN (1) TNSN97031A1 (en)
TR (1) TR199801490T2 (en)
TW (1) TW528598B (en)
UA (1) UA60299C2 (en)
WO (1) WO1997028813A1 (en)
ZA (1) ZA97910B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2766180A1 (en) * 1997-07-17 1999-01-22 Rhone Poulenc Rorer Sa MEDICINAL PRODUCTS CONTAINING AS ACTIVE SUBSTANCE A 2- (1,2,3,4-TETRAHYDROXYBUTYL) PYRAZINE DERIVATIVE, NEW DERIVATIVES OF 2- (1,2,3,4-TETRAHYDROXYBUTYL) PYRAZINE AND THEIR PREPARATION
FR2766184B1 (en) * 1997-07-17 2000-11-17 Rhone Poulenc Rorer Sa MEDICAMENTS CONTAINING AS AN ACTIVE INGREDIENT AT LEAST ONE POLYHYDROXYLALKYLPYRAZINE DERIVATIVE, THE NEW POLYHYDROXYLALKYLPYRAZINE DERIVATIVES AND THEIR PREPARATION
FR2766183B1 (en) 1997-07-17 1999-08-27 Rhone Poulenc Rorer Sa MEDICINES CONTAINING NEW POLYHYDROXYBUTYLPYRAZINES, NEW POLYHYDROXYBUTYLPYRAZINES AND THEIR PREPARATION
FR2766182A1 (en) * 1997-07-17 1999-01-22 Rhone Poulenc Rorer Sa MEDICAMENTS CONTAINING POLYHYDROXYALKYLPYRAZINE DERIVATIVES, THE NEW POLYHYDROXYALKYLPYRAZINE DERIVATIVES AND THEIR PREPARATION
NZ502055A (en) 1997-07-17 2001-09-28 Rhone Poulenc Rorer S Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them
FR2766185B1 (en) * 1997-07-18 2001-06-15 Rhone Poulenc Rorer Sa MEDICINAL PRODUCTS CONTAINING AS AT LEAST ONE SUBSTITUTED POLYHYDROXYLALKYLPYRAZINE DERIVATIVE, THE NEW POLYHYDROXYLALKYLPYRAZINE DERIVATIVES AND THEIR PREPARATION
FR2781155B1 (en) * 1998-07-16 2001-10-26 Rhone Poulenc Rorer Sa MEDICAMENTS CONTAINING POLYHYDROXYALKYLPYRAZINE DERIVATIVES, NEW POLYHYDROXYALKYLPYRAZINE DERIVATIVES AND THEIR PREPARATION
FR2788274B1 (en) * 1999-01-11 2001-02-09 Aventis Pharma Sa NOVEL POLYHYDROXYPYRAZINE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AU5844300A (en) * 1999-06-04 2000-12-28 Indian Council Of Medical Research Eugenia jambolina fruit extracts for treating diabetes
WO2001026659A1 (en) * 1999-10-12 2001-04-19 Lareida Juerg Medicament for treatment of neuropathies
FR2802814B1 (en) * 1999-12-23 2002-02-22 Aventis Pharma Sa COMBINATION OF DEOXYFRUCTOSAZINE AND AN ANTIDIABETIC FROM THE SULFONYLUREA FAMILY
FR2803515B1 (en) * 2000-01-06 2002-08-02 Aventis Pharma Sa STABLE AQUEOUS SOLUTION OF DEOXYFRUCTOSAZINE
AUPQ987400A0 (en) * 2000-09-04 2000-09-28 Food Ingredients Technologies Intangibles (Bermuda) Limited Process for selectively extracting bioactive components
US20050255180A1 (en) * 2004-05-14 2005-11-17 Gaurav Tewari Prevention of diabetes by medicinal plants & fruits
JP4615256B2 (en) * 2004-06-03 2011-01-19 株式会社エヌ・ティー・エイチ Constituents of Myrtaceae plants and their uses
US20060266975A1 (en) * 2005-05-27 2006-11-30 Nappa Mario J Compositions comprising 3,3,4,4,5,5,6,6,6-nonafluoro-1-hexene
WO2008004119A2 (en) * 2006-07-06 2008-01-10 Avestha, Gengraine, Technologies, Pvt., Ltd. Eugenia jambolana plant extracts for treating osteoporosis and the extraction process thereof
CN102552231A (en) * 2011-12-23 2012-07-11 苏州大学 Application of sodium oxamate in preparation of (fat mass and obesity) FTO enzyme inhibitor and weight-losing medicine
CN113367166B (en) * 2021-05-13 2022-07-26 海南大学 Eugenia jambolana extract bactericide as well as preparation method and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6114M (en) * 1967-01-19 1968-06-17
US3660571A (en) * 1968-03-28 1972-05-02 Takeda Chemical Industries Ltd Disease control composition for silkworms
DE2159923C3 (en) * 1971-12-02 1974-05-22 Schwabe, Willmar, Dr., 7500 Karlsruhe-Durlach Process for obtaining a substance with an insulin-like effect and medicinal preparations containing these substances
JPS5390401A (en) * 1977-01-13 1978-08-09 Japan Tobacco & Salt Public Improving of smoking taste of cigarette
FR2465484A1 (en) * 1979-09-21 1981-03-27 Urwerg Suzanne Extract of e.g. eugenia jambolana lamarck - has antidiabetic, hypoglycaemic, hypolipaemic, weight reducing anorexic and anti-cataract activity

Also Published As

Publication number Publication date
NO318694B1 (en) 2005-04-25
NO983592L (en) 1998-08-05
FR2744365A1 (en) 1997-08-08
TW528598B (en) 2003-04-21
MA24077A1 (en) 1997-10-01
EP0879058A1 (en) 1998-11-25
JP4570694B2 (en) 2010-10-27
FR2744365B1 (en) 1998-02-27
JP2010053133A (en) 2010-03-11
SK105298A3 (en) 1998-12-02
ATE201826T1 (en) 2001-06-15
UA60299C2 (en) 2003-10-15
BR9707613A (en) 1999-07-27
EA199800692A1 (en) 1999-02-25
AU726628B2 (en) 2000-11-16
US6300375B1 (en) 2001-10-09
US20020051828A1 (en) 2002-05-02
IL125598A (en) 2002-04-21
BG63288B1 (en) 2001-09-28
CZ292800B6 (en) 2003-12-17
KR19990082343A (en) 1999-11-25
DE69705108D1 (en) 2001-07-12
TR199801490T2 (en) 1998-10-21
AR005726A1 (en) 1999-07-14
TNSN97031A1 (en) 1999-12-31
EP0879058B1 (en) 2001-06-06
KR100494625B1 (en) 2005-09-30
CN1148178C (en) 2004-05-05
JP2001500103A (en) 2001-01-09
HU227958B1 (en) 2012-07-30
HUP9902586A3 (en) 2000-01-28
WO1997028813A1 (en) 1997-08-14
CN1080566C (en) 2002-03-13
BG102673A (en) 1999-09-30
PT879058E (en) 2001-10-31
PL186798B1 (en) 2004-02-27
HUP9902586A2 (en) 1999-12-28
ZA97910B (en) 1997-08-01
EA001463B1 (en) 2001-04-23
US5972342A (en) 1999-10-26
IL125598A0 (en) 1999-03-12
CN1325685A (en) 2001-12-12
DE69705108T2 (en) 2001-12-20
CN1210469A (en) 1999-03-10
CZ243698A3 (en) 1998-11-11
CA2245701C (en) 2007-09-25
AU1727197A (en) 1997-08-28
SK282672B6 (en) 2002-11-06
NO983592D0 (en) 1998-08-05
RS49527B (en) 2006-12-15
US6194412B1 (en) 2001-02-27
JP5033857B2 (en) 2012-09-26
CA2245701A1 (en) 1997-08-14
DZ2174A1 (en) 2002-12-01
DK0879058T3 (en) 2001-09-03
NZ331241A (en) 1999-09-29
YU4197A (en) 1999-07-28
GR3036007T3 (en) 2001-09-28
PL328415A1 (en) 1999-01-18

Similar Documents

Publication Publication Date Title
ES2158496T3 (en) ISOLABLE MIXTURES FROM LAMARCK JAMBOLAN EUGEN GRAINS, ITS PREPARATION AND THE USE OF THESE BLENDS AND SOME OF ITS CONSTITUENTS AS MEDICATIONS.
AR005703A1 (en) SUBSTITUTED OXAZOLIDINONES, PROCEDURE FOR THE PREPARATION, USE OF THE SAME TO PREPARE MEDICINES AND MEDICINES THAT CONTAIN THEM
AR010346A1 (en) BENZOFURANE-DERIVED COMPOUNDS; ITS USES, AND THE PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
ES2098140T3 (en) LIOSPHERES CONTAINING GONADOTROPIN.
CO4290424A1 (en) PIRAZOLOPIRIDINES, PYRROLOPYRIDIDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCEDURES FOR ITS ADMINISTRATION AS AN ANTAGONIST OF THE CORTICO-TROPINE RELEASE FACTOR
GT200500007A (en) [1,8] NAFTIRIDIN-2-WAVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA.
AR066982A2 (en) HETEROAROMATIC COMPOUNDS REPLACED AS INHIBIDORESS TIROSIN QUINASA, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE PREPARATION OF MEDICINES
AR091405A2 (en) OMEGA-CARBOXIARIL DIFENIL UREA REPLACED WITH FLUORO AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
SV2001000004A (en) DIFENIL UREAS W-CARBOXYARIL SUBSTITUTED, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND THEIR USE AS RAF QUINASA INHIBITORS
BR0207726A (en) Pharmaceutical Salts
BR9813488A (en) Mattress structure.
ES2169147T3 (en) DERIVATIVES OF BETA-CARBOLINA AGONISTAS DE MELATONINA, ITS PREPARATION PROCEDURES AND ITS USE BY A MEDICINAL TITLE.
MX9203394A (en) SUBSTITUTED BENZAZEPINES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ES2170460T3 (en) TRIAROMATIC COMPOUNDS, COMPOSITIONS THAT CONTAIN THEM AND USES.
ES2061688T3 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A CALCITONINE AND A GLICIRRICINATE AS IMPROVER OF ABSORPTION.
ES2172937T3 (en) 21-HYDROXI-6,19-OXIDOPROGESTERONE (21OH-6OP) AS A MEDICINAL PRODUCT TO TREAT THE EXCESS OF GLUCOCORTICOIDS.
AR002982A1 (en) Benzonitriles and benzofluorides, a procedure to prepare them, their use to prepare drugs, a drug made from these compounds, the pharmaceutical preparations containing them and a procedure to obtain these pharmaceutical preparations.
ES2192668T3 (en) BICYCLIC-AROMATIC COMPOUNDS.
MX9102580A (en) NEW BENZODIACEPINONAS, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
ES2124069T3 (en) AROMATIC HETERO-CYCLE COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM AND USES.
AR024846A1 (en) COSMETIC COMPOSITIONS FOR SKIN CARE CONTAINING 4-CHROMANONE.
GT200200279A (en) ANTIBODY INHIBITING THE ACTIVITY OF THE PRECURSOR CELL FACTOR AND ITS USE FOR THE TREATMENT OF ASTHMA
AR023511A1 (en) COMPOSITION THAT INCLUDES (S) AND (R) 5-AMINO-3-CIANO-1- (2,6-DICLORO-4-TRIFLUOROMETILFENIL) -4-TRIFLUORO-METILSULFINILPIRAZOL, SUCH ISOLATED COMPOUNDS AND USES OF THE SAME AS PESTICIDE
ES2177811T3 (en) USE OF NITROFLAVONOIDS FOR THE TREATMENT OF ANXIETY.
PT946567E (en) NEW CAMPOTECETIC ANALOGS, ITS USE AS MOODS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Legal Events

Date Code Title Description
FA2A Application withdrawn

Effective date: 20000809

FG2A Definitive protection

Ref document number: 879058

Country of ref document: ES